孕期糖尿病对新生儿出生结果的影响
Ying Liu1, Meixia Wang1, Jin Zhou2
1Obstetrical Department VIII, The Fourth Hospital of Shijiazhuang, Shijiazhuang, Hebei, China.
British journal of hospital medicine (London, England : 2005)
|December 2, 2024
概括
孕期糖尿病 (GDM) 与母亲的晚年,更高的BMI和不良的生活方式选择有关. GDM增加了新生儿不良后果的风险,如巨和低血糖症.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 内分泌学 在内分泌学.
背景情况:
- 孕期糖尿病 (GDM) 对母亲和新生儿的健康构成重大风险.
- 了解风险因素和结果对于有效的产前护理和管理至关重要.
研究的目的:
- 调查与妊娠糖尿病相关的危险因素.
- 评估GDM对新生儿出生结果的影响.
主要方法:
- 一项涉及2010名患有GDM的母亲和2087名正常葡萄糖耐受 (NGT) 的母亲的比较研究.
- 收集关于母亲特征,生活方式因素和新生儿出生结果的数据.
主要成果:
- 在GDM组中,产妇年龄较高,BMI较高,饮食习惯不规则的比例较高.
- 在GDM组中观察到的宏观性,新生儿低血糖症,高白血症和ARDS的发病率增加.
- 低血糖控制和高妊娠前的BMI与GDM患者的不良结果有显著的相关性.
结论:
- 患GDM的危险因素包括母亲的晚年,怀孕前的BMI (体重不足到肥胖),不规则的饮食,营养不足和缺乏运动.
- GDM与更高的不良妊娠结果发生率有关.
- 血糖控制和妊娠前BMI的有效管理对于减轻GDM的负面结果至关重要.
相关概念视频
Pathophysiology of Diabetes
866
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
866
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
504
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
504
Glucose Transporters
22.5K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.5K


